nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—ADRA2B—hypertension	0.0595	0.174	CbGaD
Cabergoline—HTR2B—hypertension	0.0491	0.143	CbGaD
Cabergoline—ADRA1A—hypertension	0.0368	0.107	CbGaD
Cabergoline—HTR7—hypertension	0.0304	0.0886	CbGaD
Cabergoline—HTR1B—hypertension	0.0294	0.0858	CbGaD
Cabergoline—DRD3—hypertension	0.0286	0.0833	CbGaD
Cabergoline—ADRA2A—hypertension	0.0261	0.076	CbGaD
Cabergoline—ADRB1—hypertension	0.026	0.0759	CbGaD
Cabergoline—ADRB2—hypertension	0.0219	0.0639	CbGaD
Cabergoline—DRD2—hypertension	0.0198	0.0577	CbGaD
Cabergoline—HTR2A—hypertension	0.0153	0.0446	CbGaD
Cabergoline—DRD5—Fenoldopam—hypertension	0.0124	0.0302	CbGbCtD
Cabergoline—ADRB2—Esmolol—hypertension	0.0101	0.0247	CbGbCtD
Cabergoline—ADRB1—Esmolol—hypertension	0.00994	0.0243	CbGbCtD
Cabergoline—HTR1B—Pindolol—hypertension	0.00819	0.02	CbGbCtD
Cabergoline—ADRA2C—Guanabenz—hypertension	0.008	0.0195	CbGbCtD
Cabergoline—ADRA1D—Terazosin—hypertension	0.0077	0.0188	CbGbCtD
Cabergoline—ADRB2—Nadolol—hypertension	0.00765	0.0187	CbGbCtD
Cabergoline—ADRB2—Nebivolol—hypertension	0.00765	0.0187	CbGbCtD
Cabergoline—ADRB2—Labetalol—hypertension	0.00765	0.0187	CbGbCtD
Cabergoline—ADRA2B—Guanabenz—hypertension	0.00759	0.0185	CbGbCtD
Cabergoline—ADRB1—Nebivolol—hypertension	0.00753	0.0184	CbGbCtD
Cabergoline—ADRB1—Nadolol—hypertension	0.00753	0.0184	CbGbCtD
Cabergoline—ADRB1—Labetalol—hypertension	0.00753	0.0184	CbGbCtD
Cabergoline—ADRA2B—Guanfacine—hypertension	0.00705	0.0172	CbGbCtD
Cabergoline—ADRB2—Acebutolol—hypertension	0.007	0.0171	CbGbCtD
Cabergoline—ADRA1D—Fenoldopam—hypertension	0.00696	0.017	CbGbCtD
Cabergoline—ADRB1—Acebutolol—hypertension	0.00689	0.0168	CbGbCtD
Cabergoline—HTR1B—Penbutolol—hypertension	0.00667	0.0163	CbGbCtD
Cabergoline—ADRB2—Metoprolol—hypertension	0.0065	0.0159	CbGbCtD
Cabergoline—ADRB2—Pindolol—hypertension	0.0065	0.0159	CbGbCtD
Cabergoline—ADRA1D—Doxazosin—hypertension	0.00642	0.0157	CbGbCtD
Cabergoline—ADRB1—Metoprolol—hypertension	0.00641	0.0157	CbGbCtD
Cabergoline—ADRB1—Pindolol—hypertension	0.00641	0.0157	CbGbCtD
Cabergoline—DRD1—Fenoldopam—hypertension	0.00632	0.0154	CbGbCtD
Cabergoline—ADRA2C—Fenoldopam—hypertension	0.00632	0.0154	CbGbCtD
Cabergoline—HTR1A—Nebivolol—hypertension	0.00603	0.0147	CbGbCtD
Cabergoline—ADRA2B—Fenoldopam—hypertension	0.006	0.0147	CbGbCtD
Cabergoline—ADRB2—Betaxolol—hypertension	0.0058	0.0142	CbGbCtD
Cabergoline—ADRA2A—Methyldopa—hypertension	0.00577	0.0141	CbGbCtD
Cabergoline—ADRB1—Betaxolol—hypertension	0.00571	0.014	CbGbCtD
Cabergoline—ADRA1B—Terazosin—hypertension	0.0056	0.0137	CbGbCtD
Cabergoline—HTR1D—Prazosin—hypertension	0.0055	0.0134	CbGbCtD
Cabergoline—ADRB2—Penbutolol—hypertension	0.0053	0.013	CbGbCtD
Cabergoline—ADRA1D—Prazosin—hypertension	0.00528	0.0129	CbGbCtD
Cabergoline—ADRA2A—Guanabenz—hypertension	0.00528	0.0129	CbGbCtD
Cabergoline—ADRB1—Penbutolol—hypertension	0.00522	0.0128	CbGbCtD
Cabergoline—HTR1A—Pindolol—hypertension	0.00513	0.0125	CbGbCtD
Cabergoline—ADRA1B—Fenoldopam—hypertension	0.00507	0.0124	CbGbCtD
Cabergoline—ADRA2A—Guanfacine—hypertension	0.0049	0.012	CbGbCtD
Cabergoline—ADRA1B—Doxazosin—hypertension	0.00468	0.0114	CbGbCtD
Cabergoline—ADRA1D—Nicardipine—hypertension	0.00455	0.0111	CbGbCtD
Cabergoline—ADRA1D—Carvedilol—hypertension	0.00455	0.0111	CbGbCtD
Cabergoline—ADRA2B—Prazosin—hypertension	0.00454	0.0111	CbGbCtD
Cabergoline—ADRA1A—Terazosin—hypertension	0.00442	0.0108	CbGbCtD
Cabergoline—HTR1B—Propranolol—hypertension	0.00419	0.0102	CbGbCtD
Cabergoline—HTR1A—Penbutolol—hypertension	0.00418	0.0102	CbGbCtD
Cabergoline—ADRA2A—Fenoldopam—hypertension	0.00417	0.0102	CbGbCtD
Cabergoline—ADRA2C—Carvedilol—hypertension	0.00414	0.0101	CbGbCtD
Cabergoline—ADRA1A—Fenoldopam—hypertension	0.004	0.00977	CbGbCtD
Cabergoline—ADRA1D—Clonidine—hypertension	0.004	0.00977	CbGbCtD
Cabergoline—ADRA2B—Carvedilol—hypertension	0.00392	0.00959	CbGbCtD
Cabergoline—ADRA2A—Doxazosin—hypertension	0.00385	0.00941	CbGbCtD
Cabergoline—DRD2—Fenoldopam—hypertension	0.00384	0.00939	CbGbCtD
Cabergoline—ADRA1B—Prazosin—hypertension	0.00384	0.00939	CbGbCtD
Cabergoline—ADRA1B—vas deferens—hypertension	0.00375	0.101	CbGeAlD
Cabergoline—ADRB2—Timolol—hypertension	0.00374	0.00913	CbGbCtD
Cabergoline—ADRA1A—Doxazosin—hypertension	0.00369	0.00902	CbGbCtD
Cabergoline—ADRB1—Timolol—hypertension	0.00368	0.00899	CbGbCtD
Cabergoline—ADRA2C—Clonidine—hypertension	0.00363	0.00887	CbGbCtD
Cabergoline—ADRB2—Carvedilol—hypertension	0.00362	0.00884	CbGbCtD
Cabergoline—ADRB1—Carvedilol—hypertension	0.00356	0.00871	CbGbCtD
Cabergoline—ADRA2B—Clonidine—hypertension	0.00344	0.00842	CbGbCtD
Cabergoline—ADRB2—Propranolol—hypertension	0.00333	0.00814	CbGbCtD
Cabergoline—ADRA1B—Carvedilol—hypertension	0.00332	0.0081	CbGbCtD
Cabergoline—ADRA1B—Nicardipine—hypertension	0.00332	0.0081	CbGbCtD
Cabergoline—HTR1A—Prazosin—hypertension	0.0033	0.00807	CbGbCtD
Cabergoline—ADRB1—Propranolol—hypertension	0.00328	0.00801	CbGbCtD
Cabergoline—ADRA2A—Prazosin—hypertension	0.00316	0.00772	CbGbCtD
Cabergoline—ADRA1A—Prazosin—hypertension	0.00303	0.00741	CbGbCtD
Cabergoline—ADRA1B—Clonidine—hypertension	0.00291	0.00711	CbGbCtD
Cabergoline—ADRA2A—Carvedilol—hypertension	0.00273	0.00667	CbGbCtD
Cabergoline—HTR7—umbilical artery—hypertension	0.00271	0.0733	CbGeAlD
Cabergoline—HTR1A—Propranolol—hypertension	0.00262	0.00641	CbGbCtD
Cabergoline—ADRA1A—Nicardipine—hypertension	0.00262	0.00639	CbGbCtD
Cabergoline—ADRA1A—Carvedilol—hypertension	0.00262	0.00639	CbGbCtD
Cabergoline—ADRA2A—Clonidine—hypertension	0.0024	0.00585	CbGbCtD
Cabergoline—ADRA1A—Clonidine—hypertension	0.0023	0.00561	CbGbCtD
Cabergoline—HTR7—vas deferens—hypertension	0.00219	0.059	CbGeAlD
Cabergoline—HTR7—superior cervical ganglion—hypertension	0.00182	0.0491	CbGeAlD
Cabergoline—CYP3A4—Guanethidine—hypertension	0.00161	0.00393	CbGbCtD
Cabergoline—HTR7—locus ceruleus—hypertension	0.00126	0.0339	CbGeAlD
Cabergoline—CYP3A4—Hydralazine—hypertension	0.00122	0.00298	CbGbCtD
Cabergoline—CYP3A4—Guanfacine—hypertension	0.00104	0.00253	CbGbCtD
Cabergoline—HTR7—pulmonary artery—hypertension	0.00102	0.0276	CbGeAlD
Cabergoline—HTR7—sympathetic nervous system—hypertension	0.000993	0.0268	CbGeAlD
Cabergoline—HTR2A—arteriole—hypertension	0.000972	0.0262	CbGeAlD
Cabergoline—HTR7—vagus nerve—hypertension	0.000962	0.026	CbGeAlD
Cabergoline—HTR7—vein—hypertension	0.000929	0.0251	CbGeAlD
Cabergoline—CYP3A4—Isradipine—hypertension	0.000925	0.00226	CbGbCtD
Cabergoline—CYP3A4—Nisoldipine—hypertension	0.000814	0.00199	CbGbCtD
Cabergoline—CYP3A4—Indapamide—hypertension	0.000814	0.00199	CbGbCtD
Cabergoline—CYP3A4—Diltiazem—hypertension	0.000786	0.00192	CbGbCtD
Cabergoline—CYP3A4—Eplerenone—hypertension	0.000786	0.00192	CbGbCtD
Cabergoline—HTR2A—locus ceruleus—hypertension	0.000783	0.0211	CbGeAlD
Cabergoline—CYP3A4—Enalapril—hypertension	0.000701	0.00171	CbGbCtD
Cabergoline—HTR7—autonomic nervous system—hypertension	0.000667	0.018	CbGeAlD
Cabergoline—CYP3A4—Irbesartan—hypertension	0.000641	0.00157	CbGbCtD
Cabergoline—HTR2A—pulmonary artery—hypertension	0.000637	0.0172	CbGeAlD
Cabergoline—CYP3A4—Amlodipine—hypertension	0.000628	0.00154	CbGbCtD
Cabergoline—HTR2A—sympathetic nervous system—hypertension	0.000619	0.0167	CbGeAlD
Cabergoline—CYP3A4—Felodipine—hypertension	0.000606	0.00148	CbGbCtD
Cabergoline—HTR2A—vagus nerve—hypertension	0.0006	0.0162	CbGeAlD
Cabergoline—CYP3A4—Nifedipine—hypertension	0.000586	0.00143	CbGbCtD
Cabergoline—HTR2A—vein—hypertension	0.000579	0.0156	CbGeAlD
Cabergoline—CYP3A4—Carvedilol—hypertension	0.000577	0.00141	CbGbCtD
Cabergoline—CYP3A4—Nicardipine—hypertension	0.000577	0.00141	CbGbCtD
Cabergoline—ADRB2—Treprostinil—Nadolol—hypertension	0.000574	1	CbGdCrCtD
Cabergoline—CYP3A4—Propranolol—hypertension	0.000531	0.0013	CbGbCtD
Cabergoline—CYP3A4—Clonidine—hypertension	0.000507	0.00124	CbGbCtD
Cabergoline—HTR1B—artery—hypertension	0.000491	0.0132	CbGeAlD
Cabergoline—HTR1D—artery—hypertension	0.000475	0.0128	CbGeAlD
Cabergoline—CYP3A4—Atorvastatin—hypertension	0.000451	0.0011	CbGbCtD
Cabergoline—DRD4—heart—hypertension	0.000443	0.012	CbGeAlD
Cabergoline—HTR2A—autonomic nervous system—hypertension	0.000416	0.0112	CbGeAlD
Cabergoline—CYP3A4—Losartan—hypertension	0.000413	0.00101	CbGbCtD
Cabergoline—HTR2A—hindlimb—hypertension	0.000385	0.0104	CbGeAlD
Cabergoline—HTR1B—blood vessel—hypertension	0.000382	0.0103	CbGeAlD
Cabergoline—HTR7—artery—hypertension	0.000378	0.0102	CbGeAlD
Cabergoline—HTR1D—blood vessel—hypertension	0.00037	0.00999	CbGeAlD
Cabergoline—CYP3A4—Verapamil—hypertension	0.000364	0.000891	CbGbCtD
Cabergoline—HTR2A—urine—hypertension	0.000339	0.00916	CbGeAlD
Cabergoline—Pergolide—ADRA2B—hypertension	0.000334	0.123	CrCbGaD
Cabergoline—HTR7—endothelium—hypertension	0.00032	0.00863	CbGeAlD
Cabergoline—CYP3A4—urine—hypertension	0.000314	0.00848	CbGeAlD
Cabergoline—HTR7—blood vessel—hypertension	0.000295	0.00796	CbGeAlD
Cabergoline—Lisuride—ADRA2B—hypertension	0.00029	0.107	CrCbGaD
Cabergoline—Pergolide—HTR2B—hypertension	0.000276	0.101	CrCbGaD
Cabergoline—ADRB1—cardiac ventricle—hypertension	0.000259	0.00699	CbGeAlD
Cabergoline—DRD1—brainstem—hypertension	0.000258	0.00696	CbGeAlD
Cabergoline—ADRB1—myocardium—hypertension	0.000244	0.00658	CbGeAlD
Cabergoline—Lisuride—HTR2B—hypertension	0.000239	0.0879	CrCbGaD
Cabergoline—HTR2A—artery—hypertension	0.000236	0.00637	CbGeAlD
Cabergoline—ADRA1B—kidney—hypertension	0.000221	0.00596	CbGeAlD
Cabergoline—HTR1B—brainstem—hypertension	0.000209	0.00564	CbGeAlD
Cabergoline—Pergolide—ADRA1A—hypertension	0.000207	0.0759	CrCbGaD
Cabergoline—HTR1D—brainstem—hypertension	0.000202	0.00546	CbGeAlD
Cabergoline—HTR2C—brainstem—hypertension	0.0002	0.00541	CbGeAlD
Cabergoline—HTR2A—endothelium—hypertension	0.000199	0.00538	CbGeAlD
Cabergoline—ADRA2C—cardiac ventricle—hypertension	0.000195	0.00527	CbGeAlD
Cabergoline—DRD5—endocrine gland—hypertension	0.000189	0.0051	CbGeAlD
Cabergoline—HTR2A—blood vessel—hypertension	0.000184	0.00496	CbGeAlD
Cabergoline—ADRA2C—myocardium—hypertension	0.000184	0.00496	CbGeAlD
Cabergoline—DRD3—central nervous system—hypertension	0.000182	0.00491	CbGeAlD
Cabergoline—HTR1B—cardiovascular system—hypertension	0.000171	0.0046	CbGeAlD
Cabergoline—DRD5—central nervous system—hypertension	0.00017	0.0046	CbGeAlD
Cabergoline—ADRB1—heart—hypertension	0.00017	0.00459	CbGeAlD
Cabergoline—HTR1A—brainstem—hypertension	0.000169	0.00455	CbGeAlD
Cabergoline—HTR2B—adrenal cortex—hypertension	0.000168	0.00454	CbGeAlD
Cabergoline—Pergolide—HTR1B—hypertension	0.000165	0.0607	CrCbGaD
Cabergoline—HTR1D—cardiovascular system—hypertension	0.000165	0.00446	CbGeAlD
Cabergoline—HTR2B—heart—hypertension	0.000163	0.00439	CbGeAlD
Cabergoline—HTR1D—kidney—hypertension	0.000162	0.00436	CbGeAlD
Cabergoline—HTR2B—smooth muscle tissue—hypertension	0.000161	0.00436	CbGeAlD
Cabergoline—HTR7—brainstem—hypertension	0.000161	0.00435	CbGeAlD
Cabergoline—Pergolide—DRD3—hypertension	0.000161	0.0589	CrCbGaD
Cabergoline—ADRB1—cardiovascular system—hypertension	0.00016	0.00433	CbGeAlD
Cabergoline—HTR2B—decidua—hypertension	0.000158	0.00427	CbGeAlD
Cabergoline—ADRA1A—brainstem—hypertension	0.000155	0.0042	CbGeAlD
Cabergoline—HTR2B—cardiovascular system—hypertension	0.000154	0.00415	CbGeAlD
Cabergoline—DRD2—brainstem—hypertension	0.000152	0.00411	CbGeAlD
Cabergoline—ADRA1D—endocrine gland—hypertension	0.000152	0.00409	CbGeAlD
Cabergoline—Pergolide—ADRA2A—hypertension	0.000147	0.0538	CrCbGaD
Cabergoline—HTR2B—cortex of kidney—hypertension	0.000146	0.00395	CbGeAlD
Cabergoline—ADRB1—cardiac atrium—hypertension	0.000145	0.00393	CbGeAlD
Cabergoline—Lisuride—HTR1B—hypertension	0.000144	0.0527	CrCbGaD
Cabergoline—HTR2C—medulla oblongata—hypertension	0.00014	0.00377	CbGeAlD
Cabergoline—ADRA1B—central nervous system—hypertension	0.00014	0.00377	CbGeAlD
Cabergoline—Lisuride—DRD3—hypertension	0.000139	0.0512	CrCbGaD
Cabergoline—HTR7—heart—hypertension	0.000139	0.00376	CbGeAlD
Cabergoline—HTR7—smooth muscle tissue—hypertension	0.000138	0.00373	CbGeAlD
Cabergoline—HTR1A—cardiovascular system—hypertension	0.000138	0.00372	CbGeAlD
Cabergoline—ADRA1D—central nervous system—hypertension	0.000137	0.00369	CbGeAlD
Cabergoline—ADRA2C—nephron tubule—hypertension	0.000135	0.00363	CbGeAlD
Cabergoline—ADRA1A—heart—hypertension	0.000134	0.00363	CbGeAlD
Cabergoline—ADRA2C—adrenal cortex—hypertension	0.000132	0.00358	CbGeAlD
Cabergoline—HTR7—cardiovascular system—hypertension	0.000132	0.00355	CbGeAlD
Cabergoline—DRD1—central nervous system—hypertension	0.00013	0.00351	CbGeAlD
Cabergoline—HTR7—kidney—hypertension	0.000129	0.00347	CbGeAlD
Cabergoline—ADRA2C—heart—hypertension	0.000128	0.00346	CbGeAlD
Cabergoline—Lisuride—ADRA2A—hypertension	0.000127	0.0467	CrCbGaD
Cabergoline—Lisuride—ADRB1—hypertension	0.000127	0.0466	CrCbGaD
Cabergoline—ADRA1A—cardiovascular system—hypertension	0.000127	0.00343	CbGeAlD
Cabergoline—ADRA2C—decidua—hypertension	0.000125	0.00336	CbGeAlD
Cabergoline—HTR2B—adrenal gland—hypertension	0.000121	0.00328	CbGeAlD
Cabergoline—ADRA2C—kidney—hypertension	0.000118	0.00319	CbGeAlD
Cabergoline—HTR1B—endocrine gland—hypertension	0.000117	0.00316	CbGeAlD
Cabergoline—ADRA2C—cortex of kidney—hypertension	0.000115	0.00311	CbGeAlD
Cabergoline—HTR7—medulla oblongata—hypertension	0.000112	0.00303	CbGeAlD
Cabergoline—Pergolide—DRD2—hypertension	0.000111	0.0408	CrCbGaD
Cabergoline—ADRB1—endocrine gland—hypertension	0.00011	0.00297	CbGeAlD
Cabergoline—ADRA2C—cardiac atrium—hypertension	0.00011	0.00296	CbGeAlD
Cabergoline—HTR1A—adrenal gland—hypertension	0.000109	0.00294	CbGeAlD
Cabergoline—HTR1B—central nervous system—hypertension	0.000105	0.00285	CbGeAlD
Cabergoline—HTR7—adrenal gland—hypertension	0.000104	0.00281	CbGeAlD
Cabergoline—ADRA2C—medulla oblongata—hypertension	0.000103	0.00279	CbGeAlD
Cabergoline—ADRA2A—heart—hypertension	0.000102	0.00276	CbGeAlD
Cabergoline—HTR1D—central nervous system—hypertension	0.000102	0.00276	CbGeAlD
Cabergoline—HTR2C—central nervous system—hypertension	0.000101	0.00273	CbGeAlD
Cabergoline—HTR2A—brainstem—hypertension	0.000101	0.00271	CbGeAlD
Cabergoline—ADRA1A—adrenal gland—hypertension	0.0001	0.00271	CbGeAlD
Cabergoline—ADRA2A—decidua—hypertension	9.94e-05	0.00268	CbGeAlD
Cabergoline—ADRB1—central nervous system—hypertension	9.92e-05	0.00268	CbGeAlD
Cabergoline—Lisuride—DRD2—hypertension	9.65e-05	0.0354	CrCbGaD
Cabergoline—ADRA2C—adrenal gland—hypertension	9.56e-05	0.00258	CbGeAlD
Cabergoline—HTR2B—central nervous system—hypertension	9.49e-05	0.00256	CbGeAlD
Cabergoline—HTR1A—endocrine gland—hypertension	9.44e-05	0.00255	CbGeAlD
Cabergoline—ADRA2A—cortex of kidney—hypertension	9.19e-05	0.00248	CbGeAlD
Cabergoline—HTR7—endocrine gland—hypertension	9.02e-05	0.00244	CbGeAlD
Cabergoline—ADRA2A—cardiac atrium—hypertension	8.74e-05	0.00236	CbGeAlD
Cabergoline—ADRA1A—endocrine gland—hypertension	8.7e-05	0.00235	CbGeAlD
Cabergoline—HTR2A—heart—hypertension	8.69e-05	0.00235	CbGeAlD
Cabergoline—HTR2A—smooth muscle tissue—hypertension	8.62e-05	0.00233	CbGeAlD
Cabergoline—Pergolide—HTR2A—hypertension	8.59e-05	0.0315	CrCbGaD
Cabergoline—DRD2—endocrine gland—hypertension	8.53e-05	0.0023	CbGeAlD
Cabergoline—HTR1A—central nervous system—hypertension	8.51e-05	0.0023	CbGeAlD
Cabergoline—ADRA2A—medulla oblongata—hypertension	8.24e-05	0.00223	CbGeAlD
Cabergoline—HTR2A—cardiovascular system—hypertension	8.2e-05	0.00221	CbGeAlD
Cabergoline—HTR7—central nervous system—hypertension	8.13e-05	0.00219	CbGeAlD
Cabergoline—HTR2A—kidney—hypertension	8.02e-05	0.00217	CbGeAlD
Cabergoline—ADRA1A—central nervous system—hypertension	7.84e-05	0.00212	CbGeAlD
Cabergoline—DRD2—central nervous system—hypertension	7.69e-05	0.00208	CbGeAlD
Cabergoline—ADRA2A—adrenal gland—hypertension	7.63e-05	0.00206	CbGeAlD
Cabergoline—ADRA2C—central nervous system—hypertension	7.47e-05	0.00202	CbGeAlD
Cabergoline—Lisuride—HTR2A—hypertension	7.45e-05	0.0274	CrCbGaD
Cabergoline—CYP3A4—kidney—hypertension	7.43e-05	0.00201	CbGeAlD
Cabergoline—HTR2A—medulla oblongata—hypertension	7.01e-05	0.00189	CbGeAlD
Cabergoline—ADRA2A—endocrine gland—hypertension	6.62e-05	0.00179	CbGeAlD
Cabergoline—HTR2A—adrenal gland—hypertension	6.49e-05	0.00175	CbGeAlD
Cabergoline—ADRA2A—central nervous system—hypertension	5.96e-05	0.00161	CbGeAlD
Cabergoline—HTR2A—endocrine gland—hypertension	5.63e-05	0.00152	CbGeAlD
Cabergoline—CYP3A4—endocrine gland—hypertension	5.21e-05	0.00141	CbGeAlD
Cabergoline—HTR2A—central nervous system—hypertension	5.07e-05	0.00137	CbGeAlD
Cabergoline—CYP3A4—central nervous system—hypertension	4.69e-05	0.00127	CbGeAlD
Cabergoline—Oedema—Ramipril—hypertension	1.7e-05	0.000144	CcSEcCtD
Cabergoline—Headache—Doxazosin—hypertension	1.7e-05	0.000144	CcSEcCtD
Cabergoline—Vertigo—Lisinopril—hypertension	1.7e-05	0.000143	CcSEcCtD
Cabergoline—Dry mouth—Timolol—hypertension	1.7e-05	0.000143	CcSEcCtD
Cabergoline—Constipation—Losartan—hypertension	1.7e-05	0.000143	CcSEcCtD
Cabergoline—Pain—Losartan—hypertension	1.7e-05	0.000143	CcSEcCtD
Cabergoline—Syncope—Lisinopril—hypertension	1.7e-05	0.000143	CcSEcCtD
Cabergoline—Vomiting—Eplerenone—hypertension	1.7e-05	0.000143	CcSEcCtD
Cabergoline—Feeling abnormal—Furosemide—hypertension	1.7e-05	0.000143	CcSEcCtD
Cabergoline—Rash—Fosinopril—hypertension	1.69e-05	0.000143	CcSEcCtD
Cabergoline—Dermatitis—Fosinopril—hypertension	1.69e-05	0.000143	CcSEcCtD
Cabergoline—Vomiting—Nifedipine—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Gastrointestinal pain—Furosemide—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Rash—Eplerenone—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Headache—Fosinopril—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Hypersensitivity—Trandolapril—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Dermatitis—Eplerenone—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Diarrhoea—Valsartan—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Asthenia—Clonidine—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Feeling abnormal—Betaxolol—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Confusional state—Timolol—hypertension	1.68e-05	0.000142	CcSEcCtD
Cabergoline—Vomiting—Verapamil—hypertension	1.68e-05	0.000141	CcSEcCtD
Cabergoline—Shock—Ramipril—hypertension	1.67e-05	0.000141	CcSEcCtD
Cabergoline—Hypersensitivity—Enalapril—hypertension	1.67e-05	0.000141	CcSEcCtD
Cabergoline—Abdominal pain—Perindopril—hypertension	1.67e-05	0.000141	CcSEcCtD
Cabergoline—Palpitations—Lisinopril—hypertension	1.67e-05	0.000141	CcSEcCtD
Cabergoline—Diarrhoea—Olmesartan—hypertension	1.67e-05	0.000141	CcSEcCtD
Cabergoline—Headache—Eplerenone—hypertension	1.67e-05	0.000141	CcSEcCtD
Cabergoline—Rash—Nifedipine—hypertension	1.67e-05	0.000141	CcSEcCtD
Cabergoline—Dermatitis—Nifedipine—hypertension	1.67e-05	0.000141	CcSEcCtD
Cabergoline—Abdominal pain—Irbesartan—hypertension	1.67e-05	0.000141	CcSEcCtD
Cabergoline—Oedema—Timolol—hypertension	1.66e-05	0.00014	CcSEcCtD
Cabergoline—Loss of consciousness—Lisinopril—hypertension	1.66e-05	0.00014	CcSEcCtD
Cabergoline—Rash—Verapamil—hypertension	1.66e-05	0.00014	CcSEcCtD
Cabergoline—Dermatitis—Verapamil—hypertension	1.66e-05	0.00014	CcSEcCtD
Cabergoline—Headache—Nifedipine—hypertension	1.66e-05	0.00014	CcSEcCtD
Cabergoline—Pruritus—Clonidine—hypertension	1.66e-05	0.00014	CcSEcCtD
Cabergoline—Abdominal pain—Hydrochlorothiazide—hypertension	1.65e-05	0.00014	CcSEcCtD
Cabergoline—Headache—Verapamil—hypertension	1.65e-05	0.000139	CcSEcCtD
Cabergoline—Hypersensitivity—Telmisartan—hypertension	1.65e-05	0.000139	CcSEcCtD
Cabergoline—Nausea—Indapamide—hypertension	1.65e-05	0.000139	CcSEcCtD
Cabergoline—Nausea—Diltiazem—hypertension	1.65e-05	0.000139	CcSEcCtD
Cabergoline—Hyperhidrosis—Ramipril—hypertension	1.65e-05	0.000139	CcSEcCtD
Cabergoline—Asthenia—Trandolapril—hypertension	1.64e-05	0.000138	CcSEcCtD
Cabergoline—Shock—Timolol—hypertension	1.64e-05	0.000138	CcSEcCtD
Cabergoline—Feeling abnormal—Losartan—hypertension	1.64e-05	0.000138	CcSEcCtD
Cabergoline—Nausea—Carvedilol—hypertension	1.63e-05	0.000138	CcSEcCtD
Cabergoline—Asthenia—Enalapril—hypertension	1.63e-05	0.000138	CcSEcCtD
Cabergoline—Abdominal pain—Furosemide—hypertension	1.63e-05	0.000137	CcSEcCtD
Cabergoline—Gastrointestinal pain—Losartan—hypertension	1.62e-05	0.000137	CcSEcCtD
Cabergoline—Dizziness—Valsartan—hypertension	1.62e-05	0.000137	CcSEcCtD
Cabergoline—Anorexia—Ramipril—hypertension	1.62e-05	0.000137	CcSEcCtD
Cabergoline—Dizziness—Olmesartan—hypertension	1.62e-05	0.000136	CcSEcCtD
Cabergoline—Pruritus—Trandolapril—hypertension	1.61e-05	0.000136	CcSEcCtD
Cabergoline—Nausea—Doxazosin—hypertension	1.61e-05	0.000136	CcSEcCtD
Cabergoline—Arthralgia—Lisinopril—hypertension	1.61e-05	0.000136	CcSEcCtD
Cabergoline—Hyperhidrosis—Timolol—hypertension	1.61e-05	0.000136	CcSEcCtD
Cabergoline—Asthenia—Telmisartan—hypertension	1.61e-05	0.000136	CcSEcCtD
Cabergoline—Pruritus—Enalapril—hypertension	1.61e-05	0.000136	CcSEcCtD
Cabergoline—Anxiety—Lisinopril—hypertension	1.6e-05	0.000135	CcSEcCtD
Cabergoline—Diarrhoea—Clonidine—hypertension	1.6e-05	0.000135	CcSEcCtD
Cabergoline—Nausea—Fosinopril—hypertension	1.59e-05	0.000134	CcSEcCtD
Cabergoline—Discomfort—Lisinopril—hypertension	1.59e-05	0.000134	CcSEcCtD
Cabergoline—Hypotension—Ramipril—hypertension	1.59e-05	0.000134	CcSEcCtD
Cabergoline—Anorexia—Timolol—hypertension	1.59e-05	0.000134	CcSEcCtD
Cabergoline—Pruritus—Telmisartan—hypertension	1.59e-05	0.000134	CcSEcCtD
Cabergoline—Nausea—Eplerenone—hypertension	1.58e-05	0.000134	CcSEcCtD
Cabergoline—Dry mouth—Lisinopril—hypertension	1.57e-05	0.000133	CcSEcCtD
Cabergoline—Nausea—Nifedipine—hypertension	1.57e-05	0.000133	CcSEcCtD
Cabergoline—Abdominal pain—Losartan—hypertension	1.57e-05	0.000132	CcSEcCtD
Cabergoline—Nausea—Verapamil—hypertension	1.57e-05	0.000132	CcSEcCtD
Cabergoline—Asthenia—Captopril—hypertension	1.56e-05	0.000132	CcSEcCtD
Cabergoline—Diarrhoea—Trandolapril—hypertension	1.56e-05	0.000132	CcSEcCtD
Cabergoline—Vomiting—Valsartan—hypertension	1.56e-05	0.000132	CcSEcCtD
Cabergoline—Confusional state—Lisinopril—hypertension	1.56e-05	0.000131	CcSEcCtD
Cabergoline—Diarrhoea—Enalapril—hypertension	1.55e-05	0.000131	CcSEcCtD
Cabergoline—Hypotension—Timolol—hypertension	1.55e-05	0.000131	CcSEcCtD
Cabergoline—Hypersensitivity—Irbesartan—hypertension	1.55e-05	0.000131	CcSEcCtD
Cabergoline—Vomiting—Olmesartan—hypertension	1.55e-05	0.000131	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Ramipril—hypertension	1.55e-05	0.000131	CcSEcCtD
Cabergoline—Rash—Valsartan—hypertension	1.55e-05	0.000131	CcSEcCtD
Cabergoline—Dizziness—Clonidine—hypertension	1.55e-05	0.000131	CcSEcCtD
Cabergoline—Dermatitis—Valsartan—hypertension	1.55e-05	0.00013	CcSEcCtD
Cabergoline—Oedema—Lisinopril—hypertension	1.54e-05	0.00013	CcSEcCtD
Cabergoline—Pruritus—Captopril—hypertension	1.54e-05	0.00013	CcSEcCtD
Cabergoline—Hypersensitivity—Hydrochlorothiazide—hypertension	1.54e-05	0.00013	CcSEcCtD
Cabergoline—Rash—Olmesartan—hypertension	1.54e-05	0.00013	CcSEcCtD
Cabergoline—Insomnia—Ramipril—hypertension	1.54e-05	0.00013	CcSEcCtD
Cabergoline—Dermatitis—Olmesartan—hypertension	1.54e-05	0.00013	CcSEcCtD
Cabergoline—Headache—Valsartan—hypertension	1.54e-05	0.00013	CcSEcCtD
Cabergoline—Diarrhoea—Telmisartan—hypertension	1.53e-05	0.000129	CcSEcCtD
Cabergoline—Headache—Olmesartan—hypertension	1.53e-05	0.000129	CcSEcCtD
Cabergoline—Paraesthesia—Ramipril—hypertension	1.53e-05	0.000129	CcSEcCtD
Cabergoline—Shock—Lisinopril—hypertension	1.52e-05	0.000128	CcSEcCtD
Cabergoline—Asthenia—Perindopril—hypertension	1.52e-05	0.000128	CcSEcCtD
Cabergoline—Dyspnoea—Ramipril—hypertension	1.52e-05	0.000128	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Timolol—hypertension	1.52e-05	0.000128	CcSEcCtD
Cabergoline—Hypersensitivity—Furosemide—hypertension	1.52e-05	0.000128	CcSEcCtD
Cabergoline—Asthenia—Irbesartan—hypertension	1.51e-05	0.000128	CcSEcCtD
Cabergoline—Somnolence—Ramipril—hypertension	1.51e-05	0.000128	CcSEcCtD
Cabergoline—Dizziness—Trandolapril—hypertension	1.51e-05	0.000127	CcSEcCtD
Cabergoline—Insomnia—Timolol—hypertension	1.5e-05	0.000127	CcSEcCtD
Cabergoline—Dizziness—Enalapril—hypertension	1.5e-05	0.000127	CcSEcCtD
Cabergoline—Asthenia—Hydrochlorothiazide—hypertension	1.5e-05	0.000127	CcSEcCtD
Cabergoline—Hypersensitivity—Betaxolol—hypertension	1.5e-05	0.000127	CcSEcCtD
Cabergoline—Dyspepsia—Ramipril—hypertension	1.5e-05	0.000126	CcSEcCtD
Cabergoline—Pruritus—Perindopril—hypertension	1.5e-05	0.000126	CcSEcCtD
Cabergoline—Paraesthesia—Timolol—hypertension	1.49e-05	0.000126	CcSEcCtD
Cabergoline—Pruritus—Irbesartan—hypertension	1.49e-05	0.000126	CcSEcCtD
Cabergoline—Hyperhidrosis—Lisinopril—hypertension	1.49e-05	0.000126	CcSEcCtD
Cabergoline—Diarrhoea—Captopril—hypertension	1.49e-05	0.000126	CcSEcCtD
Cabergoline—Vomiting—Clonidine—hypertension	1.49e-05	0.000125	CcSEcCtD
Cabergoline—Dyspnoea—Timolol—hypertension	1.48e-05	0.000125	CcSEcCtD
Cabergoline—Dizziness—Telmisartan—hypertension	1.48e-05	0.000125	CcSEcCtD
Cabergoline—Pruritus—Hydrochlorothiazide—hypertension	1.48e-05	0.000125	CcSEcCtD
Cabergoline—Decreased appetite—Ramipril—hypertension	1.48e-05	0.000125	CcSEcCtD
Cabergoline—Somnolence—Timolol—hypertension	1.48e-05	0.000125	CcSEcCtD
Cabergoline—Asthenia—Furosemide—hypertension	1.48e-05	0.000125	CcSEcCtD
Cabergoline—Rash—Clonidine—hypertension	1.47e-05	0.000124	CcSEcCtD
Cabergoline—Dermatitis—Clonidine—hypertension	1.47e-05	0.000124	CcSEcCtD
Cabergoline—Anorexia—Lisinopril—hypertension	1.47e-05	0.000124	CcSEcCtD
Cabergoline—Fatigue—Ramipril—hypertension	1.47e-05	0.000124	CcSEcCtD
Cabergoline—Headache—Clonidine—hypertension	1.47e-05	0.000124	CcSEcCtD
Cabergoline—Dyspepsia—Timolol—hypertension	1.46e-05	0.000124	CcSEcCtD
Cabergoline—Hypersensitivity—Losartan—hypertension	1.46e-05	0.000123	CcSEcCtD
Cabergoline—Asthenia—Betaxolol—hypertension	1.46e-05	0.000123	CcSEcCtD
Cabergoline—Nausea—Valsartan—hypertension	1.46e-05	0.000123	CcSEcCtD
Cabergoline—Pruritus—Furosemide—hypertension	1.46e-05	0.000123	CcSEcCtD
Cabergoline—Constipation—Ramipril—hypertension	1.46e-05	0.000123	CcSEcCtD
Cabergoline—Nausea—Olmesartan—hypertension	1.45e-05	0.000122	CcSEcCtD
Cabergoline—Vomiting—Trandolapril—hypertension	1.45e-05	0.000122	CcSEcCtD
Cabergoline—Diarrhoea—Perindopril—hypertension	1.45e-05	0.000122	CcSEcCtD
Cabergoline—Decreased appetite—Timolol—hypertension	1.45e-05	0.000122	CcSEcCtD
Cabergoline—Vomiting—Enalapril—hypertension	1.44e-05	0.000122	CcSEcCtD
Cabergoline—Diarrhoea—Irbesartan—hypertension	1.44e-05	0.000122	CcSEcCtD
Cabergoline—Hypotension—Lisinopril—hypertension	1.44e-05	0.000122	CcSEcCtD
Cabergoline—Dizziness—Captopril—hypertension	1.44e-05	0.000122	CcSEcCtD
Cabergoline—Pruritus—Betaxolol—hypertension	1.44e-05	0.000122	CcSEcCtD
Cabergoline—Rash—Trandolapril—hypertension	1.44e-05	0.000121	CcSEcCtD
Cabergoline—Dermatitis—Trandolapril—hypertension	1.44e-05	0.000121	CcSEcCtD
Cabergoline—Fatigue—Timolol—hypertension	1.43e-05	0.000121	CcSEcCtD
Cabergoline—Rash—Enalapril—hypertension	1.43e-05	0.000121	CcSEcCtD
Cabergoline—Dermatitis—Enalapril—hypertension	1.43e-05	0.000121	CcSEcCtD
Cabergoline—Diarrhoea—Hydrochlorothiazide—hypertension	1.43e-05	0.000121	CcSEcCtD
Cabergoline—Headache—Trandolapril—hypertension	1.43e-05	0.000121	CcSEcCtD
Cabergoline—Vomiting—Telmisartan—hypertension	1.43e-05	0.00012	CcSEcCtD
Cabergoline—Asthenia—Losartan—hypertension	1.42e-05	0.00012	CcSEcCtD
Cabergoline—Headache—Enalapril—hypertension	1.42e-05	0.00012	CcSEcCtD
Cabergoline—Pain—Timolol—hypertension	1.42e-05	0.00012	CcSEcCtD
Cabergoline—Rash—Telmisartan—hypertension	1.41e-05	0.000119	CcSEcCtD
Cabergoline—Dermatitis—Telmisartan—hypertension	1.41e-05	0.000119	CcSEcCtD
Cabergoline—Diarrhoea—Furosemide—hypertension	1.41e-05	0.000119	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Lisinopril—hypertension	1.41e-05	0.000119	CcSEcCtD
Cabergoline—Pruritus—Losartan—hypertension	1.4e-05	0.000118	CcSEcCtD
Cabergoline—Headache—Telmisartan—hypertension	1.4e-05	0.000118	CcSEcCtD
Cabergoline—Feeling abnormal—Ramipril—hypertension	1.4e-05	0.000118	CcSEcCtD
Cabergoline—Dizziness—Perindopril—hypertension	1.4e-05	0.000118	CcSEcCtD
Cabergoline—Insomnia—Lisinopril—hypertension	1.4e-05	0.000118	CcSEcCtD
Cabergoline—Dizziness—Irbesartan—hypertension	1.39e-05	0.000118	CcSEcCtD
Cabergoline—Diarrhoea—Betaxolol—hypertension	1.39e-05	0.000118	CcSEcCtD
Cabergoline—Gastrointestinal pain—Ramipril—hypertension	1.39e-05	0.000117	CcSEcCtD
Cabergoline—Nausea—Clonidine—hypertension	1.39e-05	0.000117	CcSEcCtD
Cabergoline—Paraesthesia—Lisinopril—hypertension	1.39e-05	0.000117	CcSEcCtD
Cabergoline—Vomiting—Captopril—hypertension	1.39e-05	0.000117	CcSEcCtD
Cabergoline—Dizziness—Hydrochlorothiazide—hypertension	1.38e-05	0.000117	CcSEcCtD
Cabergoline—Dyspnoea—Lisinopril—hypertension	1.38e-05	0.000116	CcSEcCtD
Cabergoline—Rash—Captopril—hypertension	1.37e-05	0.000116	CcSEcCtD
Cabergoline—Dermatitis—Captopril—hypertension	1.37e-05	0.000116	CcSEcCtD
Cabergoline—Somnolence—Lisinopril—hypertension	1.37e-05	0.000116	CcSEcCtD
Cabergoline—Feeling abnormal—Timolol—hypertension	1.37e-05	0.000116	CcSEcCtD
Cabergoline—Headache—Captopril—hypertension	1.37e-05	0.000115	CcSEcCtD
Cabergoline—Gastrointestinal pain—Timolol—hypertension	1.36e-05	0.000115	CcSEcCtD
Cabergoline—Dizziness—Furosemide—hypertension	1.36e-05	0.000115	CcSEcCtD
Cabergoline—Dyspepsia—Lisinopril—hypertension	1.36e-05	0.000115	CcSEcCtD
Cabergoline—Diarrhoea—Losartan—hypertension	1.36e-05	0.000115	CcSEcCtD
Cabergoline—Nausea—Trandolapril—hypertension	1.36e-05	0.000114	CcSEcCtD
Cabergoline—Nausea—Enalapril—hypertension	1.35e-05	0.000114	CcSEcCtD
Cabergoline—Dizziness—Betaxolol—hypertension	1.35e-05	0.000114	CcSEcCtD
Cabergoline—Vomiting—Perindopril—hypertension	1.35e-05	0.000114	CcSEcCtD
Cabergoline—Abdominal pain—Ramipril—hypertension	1.35e-05	0.000114	CcSEcCtD
Cabergoline—Decreased appetite—Lisinopril—hypertension	1.34e-05	0.000113	CcSEcCtD
Cabergoline—Vomiting—Irbesartan—hypertension	1.34e-05	0.000113	CcSEcCtD
Cabergoline—Rash—Perindopril—hypertension	1.33e-05	0.000113	CcSEcCtD
Cabergoline—Dermatitis—Perindopril—hypertension	1.33e-05	0.000112	CcSEcCtD
Cabergoline—Nausea—Telmisartan—hypertension	1.33e-05	0.000112	CcSEcCtD
Cabergoline—Fatigue—Lisinopril—hypertension	1.33e-05	0.000112	CcSEcCtD
Cabergoline—Vomiting—Hydrochlorothiazide—hypertension	1.33e-05	0.000112	CcSEcCtD
Cabergoline—Rash—Irbesartan—hypertension	1.33e-05	0.000112	CcSEcCtD
Cabergoline—Dermatitis—Irbesartan—hypertension	1.33e-05	0.000112	CcSEcCtD
Cabergoline—Headache—Perindopril—hypertension	1.33e-05	0.000112	CcSEcCtD
Cabergoline—Headache—Irbesartan—hypertension	1.32e-05	0.000111	CcSEcCtD
Cabergoline—Constipation—Lisinopril—hypertension	1.32e-05	0.000111	CcSEcCtD
Cabergoline—Pain—Lisinopril—hypertension	1.32e-05	0.000111	CcSEcCtD
Cabergoline—Rash—Hydrochlorothiazide—hypertension	1.32e-05	0.000111	CcSEcCtD
Cabergoline—Dermatitis—Hydrochlorothiazide—hypertension	1.32e-05	0.000111	CcSEcCtD
Cabergoline—Abdominal pain—Timolol—hypertension	1.32e-05	0.000111	CcSEcCtD
Cabergoline—Dizziness—Losartan—hypertension	1.31e-05	0.000111	CcSEcCtD
Cabergoline—Headache—Hydrochlorothiazide—hypertension	1.31e-05	0.000111	CcSEcCtD
Cabergoline—Vomiting—Furosemide—hypertension	1.31e-05	0.00011	CcSEcCtD
Cabergoline—Rash—Furosemide—hypertension	1.3e-05	0.000109	CcSEcCtD
Cabergoline—Dermatitis—Furosemide—hypertension	1.3e-05	0.000109	CcSEcCtD
Cabergoline—Vomiting—Betaxolol—hypertension	1.29e-05	0.000109	CcSEcCtD
Cabergoline—Nausea—Captopril—hypertension	1.29e-05	0.000109	CcSEcCtD
Cabergoline—Headache—Furosemide—hypertension	1.29e-05	0.000109	CcSEcCtD
Cabergoline—Rash—Betaxolol—hypertension	1.28e-05	0.000108	CcSEcCtD
Cabergoline—Dermatitis—Betaxolol—hypertension	1.28e-05	0.000108	CcSEcCtD
Cabergoline—Headache—Betaxolol—hypertension	1.28e-05	0.000108	CcSEcCtD
Cabergoline—Feeling abnormal—Lisinopril—hypertension	1.27e-05	0.000107	CcSEcCtD
Cabergoline—Gastrointestinal pain—Lisinopril—hypertension	1.26e-05	0.000106	CcSEcCtD
Cabergoline—Vomiting—Losartan—hypertension	1.26e-05	0.000106	CcSEcCtD
Cabergoline—Nausea—Perindopril—hypertension	1.26e-05	0.000106	CcSEcCtD
Cabergoline—Hypersensitivity—Ramipril—hypertension	1.25e-05	0.000106	CcSEcCtD
Cabergoline—Nausea—Irbesartan—hypertension	1.25e-05	0.000106	CcSEcCtD
Cabergoline—Rash—Losartan—hypertension	1.25e-05	0.000106	CcSEcCtD
Cabergoline—Dermatitis—Losartan—hypertension	1.25e-05	0.000105	CcSEcCtD
Cabergoline—Headache—Losartan—hypertension	1.24e-05	0.000105	CcSEcCtD
Cabergoline—Nausea—Hydrochlorothiazide—hypertension	1.24e-05	0.000105	CcSEcCtD
Cabergoline—Hypersensitivity—Timolol—hypertension	1.23e-05	0.000103	CcSEcCtD
Cabergoline—Nausea—Furosemide—hypertension	1.22e-05	0.000103	CcSEcCtD
Cabergoline—Asthenia—Ramipril—hypertension	1.22e-05	0.000103	CcSEcCtD
Cabergoline—Abdominal pain—Lisinopril—hypertension	1.22e-05	0.000103	CcSEcCtD
Cabergoline—Nausea—Betaxolol—hypertension	1.21e-05	0.000102	CcSEcCtD
Cabergoline—Pruritus—Ramipril—hypertension	1.2e-05	0.000102	CcSEcCtD
Cabergoline—Asthenia—Timolol—hypertension	1.19e-05	0.000101	CcSEcCtD
Cabergoline—Nausea—Losartan—hypertension	1.18e-05	9.95e-05	CcSEcCtD
Cabergoline—Pruritus—Timolol—hypertension	1.18e-05	9.93e-05	CcSEcCtD
Cabergoline—Diarrhoea—Ramipril—hypertension	1.16e-05	9.83e-05	CcSEcCtD
Cabergoline—Diarrhoea—Timolol—hypertension	1.14e-05	9.61e-05	CcSEcCtD
Cabergoline—Hypersensitivity—Lisinopril—hypertension	1.14e-05	9.59e-05	CcSEcCtD
Cabergoline—Dizziness—Ramipril—hypertension	1.13e-05	9.5e-05	CcSEcCtD
Cabergoline—Asthenia—Lisinopril—hypertension	1.11e-05	9.34e-05	CcSEcCtD
Cabergoline—Dizziness—Timolol—hypertension	1.1e-05	9.28e-05	CcSEcCtD
Cabergoline—Pruritus—Lisinopril—hypertension	1.09e-05	9.21e-05	CcSEcCtD
Cabergoline—Vomiting—Ramipril—hypertension	1.08e-05	9.13e-05	CcSEcCtD
Cabergoline—Rash—Ramipril—hypertension	1.07e-05	9.05e-05	CcSEcCtD
Cabergoline—Dermatitis—Ramipril—hypertension	1.07e-05	9.05e-05	CcSEcCtD
Cabergoline—Headache—Ramipril—hypertension	1.07e-05	9e-05	CcSEcCtD
Cabergoline—Vomiting—Timolol—hypertension	1.06e-05	8.93e-05	CcSEcCtD
Cabergoline—Diarrhoea—Lisinopril—hypertension	1.06e-05	8.91e-05	CcSEcCtD
Cabergoline—Rash—Timolol—hypertension	1.05e-05	8.85e-05	CcSEcCtD
Cabergoline—Dermatitis—Timolol—hypertension	1.05e-05	8.84e-05	CcSEcCtD
Cabergoline—Headache—Timolol—hypertension	1.04e-05	8.79e-05	CcSEcCtD
Cabergoline—Dizziness—Lisinopril—hypertension	1.02e-05	8.61e-05	CcSEcCtD
Cabergoline—Nausea—Ramipril—hypertension	1.01e-05	8.53e-05	CcSEcCtD
Cabergoline—Nausea—Timolol—hypertension	9.88e-06	8.34e-05	CcSEcCtD
Cabergoline—Vomiting—Lisinopril—hypertension	9.81e-06	8.28e-05	CcSEcCtD
Cabergoline—Rash—Lisinopril—hypertension	9.73e-06	8.21e-05	CcSEcCtD
Cabergoline—Dermatitis—Lisinopril—hypertension	9.72e-06	8.2e-05	CcSEcCtD
Cabergoline—Headache—Lisinopril—hypertension	9.67e-06	8.16e-05	CcSEcCtD
Cabergoline—Nausea—Lisinopril—hypertension	9.17e-06	7.74e-05	CcSEcCtD
Cabergoline—ADRB2—Signaling Pathways—CDKN1A—hypertension	4.2e-07	4.72e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MYC—hypertension	4.2e-07	4.72e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL6—hypertension	4.2e-07	4.72e-06	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—AKT1—hypertension	4.2e-07	4.72e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MAPK8—hypertension	4.2e-07	4.71e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—PTEN—hypertension	4.2e-07	4.71e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TGFB1—hypertension	4.19e-07	4.71e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—AKT1—hypertension	4.18e-07	4.7e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—RELA—hypertension	4.18e-07	4.7e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SLC2A4—hypertension	4.18e-07	4.7e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GCG—hypertension	4.18e-07	4.7e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MTOR—hypertension	4.17e-07	4.68e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MAPK8—hypertension	4.16e-07	4.67e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—AKT1—hypertension	4.15e-07	4.66e-06	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—AKT1—hypertension	4.14e-07	4.65e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—hypertension	4.13e-07	4.64e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MMP9—hypertension	4.13e-07	4.64e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—EGFR—hypertension	4.11e-07	4.62e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CDKN1A—hypertension	4.11e-07	4.62e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MMP9—hypertension	4.1e-07	4.61e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MAPK8—hypertension	4.1e-07	4.61e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—PTEN—hypertension	4.1e-07	4.61e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MTOR—hypertension	4.1e-07	4.61e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—FGF2—hypertension	4.1e-07	4.6e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—RELA—hypertension	4.09e-07	4.6e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—AKT1—hypertension	4.09e-07	4.6e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CDKN1A—hypertension	4.09e-07	4.6e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—EP300—hypertension	4.09e-07	4.6e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RHOA—hypertension	4.08e-07	4.59e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—PTEN—hypertension	4.08e-07	4.59e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—EP300—hypertension	4.05e-07	4.55e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GOT1—hypertension	4.05e-07	4.55e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NOS3—hypertension	4.04e-07	4.54e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PIK3R1—hypertension	4.04e-07	4.54e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MTOR—hypertension	4.02e-07	4.51e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MAPK8—hypertension	4.01e-07	4.51e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CXCL8—hypertension	4.01e-07	4.5e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—AKT1—hypertension	4e-07	4.5e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—EP300—hypertension	4e-07	4.5e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MMP9—hypertension	3.99e-07	4.49e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MAPK8—hypertension	3.99e-07	4.49e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—AKT1—hypertension	3.98e-07	4.47e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CDKN1A—hypertension	3.98e-07	4.47e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—SRC—hypertension	3.98e-07	4.47e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—PTEN—hypertension	3.97e-07	4.46e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MYC—hypertension	3.96e-07	4.45e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TGFB1—hypertension	3.95e-07	4.44e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CXCL8—hypertension	3.94e-07	4.43e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—SRC—hypertension	3.94e-07	4.43e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MMP9—hypertension	3.93e-07	4.41e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—STK11—hypertension	3.93e-07	4.41e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP19A1—hypertension	3.93e-07	4.41e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CDKN1A—hypertension	3.92e-07	4.4e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—EP300—hypertension	3.91e-07	4.4e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MYC—hypertension	3.91e-07	4.39e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MYC—hypertension	3.91e-07	4.39e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—PTEN—hypertension	3.91e-07	4.39e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TGFB1—hypertension	3.9e-07	4.38e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TGFB1—hypertension	3.9e-07	4.38e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—EP300—hypertension	3.89e-07	4.37e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—SRC—hypertension	3.89e-07	4.37e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MAPK8—hypertension	3.88e-07	4.36e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—EGFR—hypertension	3.88e-07	4.36e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—VEGFA—hypertension	3.87e-07	4.35e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—AKT1—hypertension	3.87e-07	4.35e-06	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—AKT1—hypertension	3.87e-07	4.35e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CXCL8—hypertension	3.86e-07	4.34e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PTEN—hypertension	3.86e-07	4.33e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—VEGFA—hypertension	3.84e-07	4.31e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—EGFR—hypertension	3.83e-07	4.3e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—EGFR—hypertension	3.83e-07	4.3e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MAPK8—hypertension	3.82e-07	4.29e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—AKT1—hypertension	3.81e-07	4.28e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—hypertension	3.81e-07	4.28e-06	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—AKT1—hypertension	3.81e-07	4.28e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RELA—hypertension	3.8e-07	4.27e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—SRC—hypertension	3.8e-07	4.27e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—VEGFA—hypertension	3.79e-07	4.26e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—EP300—hypertension	3.79e-07	4.25e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—SRC—hypertension	3.78e-07	4.25e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TP53—hypertension	3.78e-07	4.24e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TP53—hypertension	3.75e-07	4.22e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—hypertension	3.75e-07	4.21e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MTOR—hypertension	3.73e-07	4.19e-06	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—AKT1—hypertension	3.73e-07	4.19e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—EP300—hypertension	3.73e-07	4.19e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—VEGFA—hypertension	3.71e-07	4.16e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—VEGFA—hypertension	3.69e-07	4.14e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—SRC—hypertension	3.68e-07	4.14e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—EP300—hypertension	3.68e-07	4.13e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TP53—hypertension	3.68e-07	4.13e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—hypertension	3.67e-07	4.12e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—COMT—hypertension	3.65e-07	4.1e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—SRC—hypertension	3.62e-07	4.07e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MMP9—hypertension	3.62e-07	4.07e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TP53—hypertension	3.62e-07	4.06e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CDKN1A—hypertension	3.61e-07	4.06e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARGC1A—hypertension	3.6e-07	4.05e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GNB3—hypertension	3.6e-07	4.05e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PTEN—hypertension	3.6e-07	4.05e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—HMOX1—hypertension	3.59e-07	4.03e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCL8—hypertension	3.59e-07	4.03e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—VEGFA—hypertension	3.59e-07	4.03e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MMP9—hypertension	3.56e-07	4e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MYC—hypertension	3.56e-07	4e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TGFB1—hypertension	3.56e-07	3.99e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CDKN1A—hypertension	3.55e-07	3.99e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PTEN—hypertension	3.54e-07	3.98e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CAT—hypertension	3.54e-07	3.98e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MYC—hypertension	3.53e-07	3.97e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—VEGFA—hypertension	3.53e-07	3.96e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MAPK8—hypertension	3.52e-07	3.96e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TGFB1—hypertension	3.52e-07	3.96e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—AKT1—hypertension	3.51e-07	3.95e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GNAS—hypertension	3.51e-07	3.94e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MMP9—hypertension	3.49e-07	3.92e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MYC—hypertension	3.49e-07	3.92e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—EGFR—hypertension	3.49e-07	3.92e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CDKN1A—hypertension	3.48e-07	3.91e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TGFB1—hypertension	3.48e-07	3.91e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PTEN—hypertension	3.47e-07	3.9e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MAPK8—hypertension	3.47e-07	3.9e-06	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—AKT1—hypertension	3.46e-07	3.89e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—hypertension	3.46e-07	3.89e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—AKT1—hypertension	3.46e-07	3.88e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—EGFR—hypertension	3.45e-07	3.88e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TP53—hypertension	3.45e-07	3.88e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—hypertension	3.44e-07	3.86e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—EP300—hypertension	3.43e-07	3.86e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOB—hypertension	3.43e-07	3.86e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—EGFR—hypertension	3.41e-07	3.83e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—hypertension	3.41e-07	3.83e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MYC—hypertension	3.41e-07	3.83e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TGFB1—hypertension	3.4e-07	3.82e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MAPK8—hypertension	3.39e-07	3.81e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MYC—hypertension	3.39e-07	3.81e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—AKT1—hypertension	3.39e-07	3.8e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TGFB1—hypertension	3.38e-07	3.8e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—EP300—hypertension	3.38e-07	3.8e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—hypertension	3.36e-07	3.78e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSTM1—hypertension	3.34e-07	3.75e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—SRC—hypertension	3.34e-07	3.75e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—EGFR—hypertension	3.33e-07	3.75e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—EGFR—hypertension	3.32e-07	3.73e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—hypertension	3.31e-07	3.72e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—EP300—hypertension	3.31e-07	3.72e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MYC—hypertension	3.3e-07	3.71e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TGFB1—hypertension	3.29e-07	3.7e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—SRC—hypertension	3.29e-07	3.69e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—LPL—hypertension	3.28e-07	3.68e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TP53—hypertension	3.26e-07	3.66e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—VEGFA—hypertension	3.25e-07	3.65e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MYC—hypertension	3.25e-07	3.65e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MMP9—hypertension	3.24e-07	3.64e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TGFB1—hypertension	3.24e-07	3.64e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CDKN1A—hypertension	3.23e-07	3.63e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—EGFR—hypertension	3.23e-07	3.63e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PTEN—hypertension	3.22e-07	3.62e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—SRC—hypertension	3.22e-07	3.62e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TP53—hypertension	3.21e-07	3.61e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TP53—hypertension	3.21e-07	3.61e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ADCY5—hypertension	3.21e-07	3.61e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—VEGFA—hypertension	3.2e-07	3.6e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GPX1—hypertension	3.2e-07	3.59e-06	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—AKT1—hypertension	3.19e-07	3.58e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—EGFR—hypertension	3.18e-07	3.57e-06	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—AKT1—hypertension	3.17e-07	3.56e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PRKCA—hypertension	3.17e-07	3.56e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP1A1—hypertension	3.17e-07	3.56e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—hypertension	3.16e-07	3.55e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MAPK8—hypertension	3.15e-07	3.54e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—AKT1—hypertension	3.15e-07	3.53e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—VEGFA—hypertension	3.13e-07	3.52e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CD36—hypertension	3.12e-07	3.5e-06	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—AKT1—hypertension	3.1e-07	3.49e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—EP300—hypertension	3.07e-07	3.45e-06	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—AKT1—hypertension	3.05e-07	3.43e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MYC—hypertension	2.99e-07	3.36e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—SRC—hypertension	2.99e-07	3.36e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TGFB1—hypertension	2.99e-07	3.35e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—hypertension	2.98e-07	3.35e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MTHFR—hypertension	2.95e-07	3.32e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MYC—hypertension	2.95e-07	3.31e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—hypertension	2.94e-07	3.3e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—hypertension	2.94e-07	3.3e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TGFB1—hypertension	2.94e-07	3.3e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—EGFR—hypertension	2.93e-07	3.29e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TP53—hypertension	2.93e-07	3.29e-06	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—AKT1—hypertension	2.92e-07	3.28e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—VEGFA—hypertension	2.91e-07	3.27e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TP53—hypertension	2.9e-07	3.26e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARA—hypertension	2.9e-07	3.25e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MYC—hypertension	2.88e-07	3.24e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—EGFR—hypertension	2.88e-07	3.24e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TGFB1—hypertension	2.88e-07	3.23e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TP53—hypertension	2.86e-07	3.22e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—EGFR—hypertension	2.82e-07	3.17e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AGT—hypertension	2.81e-07	3.15e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TP53—hypertension	2.8e-07	3.15e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TP53—hypertension	2.79e-07	3.13e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CALM1—hypertension	2.76e-07	3.1e-06	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—AKT1—hypertension	2.75e-07	3.09e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOE—hypertension	2.75e-07	3.09e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—AKT1—hypertension	2.74e-07	3.07e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CAV1—hypertension	2.72e-07	3.06e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOA1—hypertension	2.72e-07	3.05e-06	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—AKT1—hypertension	2.71e-07	3.05e-06	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—AKT1—hypertension	2.71e-07	3.05e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TP53—hypertension	2.71e-07	3.04e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MYC—hypertension	2.68e-07	3.01e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—hypertension	2.68e-07	3.01e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TGFB1—hypertension	2.67e-07	3e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TP53—hypertension	2.67e-07	3e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—hypertension	2.65e-07	2.98e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—hypertension	2.62e-07	2.94e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—EGFR—hypertension	2.62e-07	2.94e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—hypertension	2.56e-07	2.88e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—hypertension	2.55e-07	2.86e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—hypertension	2.48e-07	2.79e-06	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—AKT1—hypertension	2.47e-07	2.78e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TP53—hypertension	2.46e-07	2.76e-06	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—AKT1—hypertension	2.45e-07	2.75e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—hypertension	2.44e-07	2.74e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TP53—hypertension	2.42e-07	2.72e-06	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—AKT1—hypertension	2.42e-07	2.72e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARG—hypertension	2.39e-07	2.69e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TP53—hypertension	2.37e-07	2.66e-06	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—AKT1—hypertension	2.36e-07	2.66e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—POMC—hypertension	2.36e-07	2.65e-06	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—AKT1—hypertension	2.35e-07	2.64e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—INS—hypertension	2.35e-07	2.64e-06	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AKT1—hypertension	2.29e-07	2.57e-06	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AKT1—hypertension	2.25e-07	2.53e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—hypertension	2.25e-07	2.53e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—AKT1—hypertension	2.22e-07	2.5e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—hypertension	2.21e-07	2.49e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TP53—hypertension	2.2e-07	2.47e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—hypertension	2.17e-07	2.44e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ALB—hypertension	2.15e-07	2.42e-06	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AKT1—hypertension	2.08e-07	2.33e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NOS3—hypertension	2.06e-07	2.31e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PIK3R1—hypertension	2.06e-07	2.31e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AKT1—hypertension	2.04e-07	2.29e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—hypertension	2.01e-07	2.26e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AKT1—hypertension	2e-07	2.25e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—hypertension	1.88e-07	2.12e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AKT1—hypertension	1.86e-07	2.09e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTEN—hypertension	1.64e-07	1.85e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—EP300—hypertension	1.57e-07	1.76e-06	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AKT1—hypertension	9.47e-08	1.06e-06	CbGpPWpGaD
